Form4insider filings, from the source

SEC Form 4 · accession 0001562180-18-005030

ARRAY BIOPHARMA INC · ARRY

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Nicholas A Saccomano
Officer — CSO
Period of report
Dec 14, 2018
Accepted (ET)
Dec 18, 2018 · 7:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100412

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 16, 2018M12,469$0.00A74,162D
Common StockF2Dec 16, 2018F5,485$15.97D68,677D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3$0.00Dec 14, 2018A23,000A—Dec 20, 2022Common Stock23,00023,000D
Stock Option (Right to Buy)F4$15.97Dec 14, 2018A138,000A—Dec 16, 2028Common Stock138,000138,000D
Restricted Stock UnitsF5$0.00Dec 16, 2018M5,469D—Dec 16, 2020Common Stock5,46910,938D
Restricted Stock UnitsF5$0.00Dec 16, 2018M7,000D—Dec 17, 2021Common Stock7,00021,000D

Explanation of responses